title: Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma.
abstract: Avoidance of facial nerve palsy is one of the major goals of vestibular schwannoma (VS) microsurgery. In this study, we examined the significance of previously implicated prognostic factors (age, tumor size, the extent of resection and the surgical approach) on post-operative facial nerve function. We selected all VS patients from prospectively collected database (1984-2009) who underwent microsurgical resection as their initial treatment for histopathologically confirmed VS. The effect of variables such as surgical approach, tumor size, patient age and extent of resection on rates facial nerve dysfunction after surgery, were analyzed using multivariate logistic regression. Patients with preoperative facial nerve dysfunction (House-Brackman [HB] score 3 or higher) were excluded, and HB grade of 1 or 2 at the last follow-up visit was defined as "facial nerve preservation." A total of 624 VS patients were included in this study. Multivariate logistic regression analysis found that only pre-operative tumor size significantly predicted poorer facial nerve outcome for patients followed-up for ≥6 and ≥12 months (OR 1.27, 95% CI 1.09-1.49, p < 0.01; OR 1.35, 95% CI 1.10-1.67, P < 0.01, respectively). We found no significant relationship between facial nerve function and age, extent of resection, surgical approach, or tumor size (when extent of resection and surgical approach were included in the regression analysis). Because facial nerve palsy is a debilitating and psychologically devastating condition for the patient, we suggest altering surgical aggressiveness in patients with unfavorable tumor anatomy, particularly in cases with large tumors where overaggressive resection might subject the patient to unwarranted risk. Residual disease can be followed and controlled with radiosurgery if interval growth is noted.
authors.affiliation: Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA.
authors.forename: Orin
authors.initials: O
authors.lastname: Bloch
authors.forename: Michael E
authors.initials: ME
authors.lastname: Sughrue
authors.forename: Rajwant
authors.initials: R
authors.lastname: Kaur
authors.forename: Ari J
authors.initials: AJ
authors.lastname: Kane
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Rutkowski
authors.forename: Gurvinder
authors.initials: G
authors.lastname: Kaur
authors.forename: Isaac
authors.initials: I
authors.lastname: Yang
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Pitts
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Parsa
mesh_terms: D005154:Facial Nerve / Q000502:physiology*; D005155:Facial Nerve Diseases / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D009464:Neuroma, Acoustic / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome